BioMarin (BMRN) Stock News Today: Amicus Acquisition Fallout, BMN 349 Cut, and Fresh Wall Street Price Targets (Dec. 22, 2025)
BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) is back in the rare-disease spotlight on December 22, 2025, as investors digest a blockbuster acquisition, a quiet pipeline pruning, and a new round of analyst price-target resets. As of 20:24 UTC (3:24 p.m. ET),